{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-115106","form_type":"8-K","ticker":"CCEL","cik":"0000862692","company_name":"CRYO CELL INTERNATIONAL INC","filed_at":"2024-10-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.172317+00:00","generated_at":"2026-05-30T13:31:03.990763+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Cryo-Cell Q3 revenue $8.07M, net income $1.05M; strategic review ongoing, spinoff on hold","bullets":["Revenue $8.07M vs $7.87M YoY; net income $1.05M ($0.13/diluted) vs $0.68M ($0.08).","Gains on marketable securities $522k vs $93k YoY, boosting earnings.","Company exploring strategic alternatives to maximize shareholder value; process ongoing.","Spinoff of Celle Corp on hold due to arbitration demand with Duke University (see Form 10-Q).","Board considering instituting regular quarterly dividend; no decision yet."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-115106","json":"https://secwatch.observer/filing/0000950170-24-115106.json","markdown":"https://secwatch.observer/filing/0000950170-24-115106.md","text":"https://secwatch.observer/filing/0000950170-24-115106.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/862692/000095017024115106/0000950170-24-115106-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/862692/000095017024115106/ccel-20241015.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T13:31:03.990763+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}